MedPath

Role of lung ultrasound in diagnosing and management of respiratory distress syndrome in 34 weeks neonates

Not Applicable
Conditions
Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere
Registration Number
CTRI/2022/07/044166
Lead Sponsor
Bharati Vidyapeeth Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

< 34 weeks neonates admitted to NICU within 6 hours of life with respiratory distress

Exclusion Criteria

1. >34 weeks

2. No respiratory distress

3. Admission beyond 6 hours of life to NIC

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the diagnostic accuracy of lung ultrasound score in predicting the need for first dose of surfactant therapy in preterm infants (34weeks) with respiratory distress. <br/ ><br>To determine the diagnostic accuracy of lung USG score in predicting the need for second dose of surfactant therapy in preterm infants(34 weeks) with respiratory distress, if indicated clinicallyTimepoint: 6 hours
Secondary Outcome Measures
NameTimeMethod
To determine the change in LUS score after six hours of surfactant therapyTimepoint: six hours after surfactant first dose;To determine the distribution of LUS score with corresponding arterial/alveolar oxygenation ratio (PaO2/PAO2)Timepoint: at admission;To determine the distribution of LUS score with corresponding chest x-ray (CXR)-based classification of RDS as mild, moderate and severe RDSTimepoint: admission;To determine the distribution of LUS score with corresponding oxygen saturation to fraction oxygenation ratio (S/F)Timepoint: admission
© Copyright 2025. All Rights Reserved by MedPath